Clinical trial

Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma

NCT01922154

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-02-01

PhasePHASE4

Study timeline

Study start (unknown)2009-02-01Date precision: month

Registry last updated2021-07-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucoma, Neovascularunresolved

Interventions

intravitreal ranibizumabDRUG

Trabeculectomy with mitomycinCPROCEDURE

Sponsors & collaborators

Siriraj Hospitallead sponsor

Mapped research locations

BangkokThailand1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01922154 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.